Trump HHS ramps up biotech to phase out animal testing

Published



The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical market. 

The Food and Drug Administration and the National Institutes of Health launched parallel initiatives to help pharmaceutical companies implement new approach methodologies during the initial stages of drug development as an alternative to animal testing, which has drawn criticism from animal rights groups.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.